Goldman Sachs expects Nvidia ’beat and raise,’ lifts price target to $240
Investing.com - IQVIA Holdings Inc. (NYSE:IQV) on Tuesday reported third-quarter results that exceeded analyst expectations, with revenue growing 5.2% YoY to $4.1 billion and adjusted earnings per share of $3.00, beating the consensus estimate of $2.97.
The clinical research and healthcare intelligence provider saw its stock edge up 0.3% following the announcement as investors responded positively to the company’s performance and reaffirmed guidance.
Revenue growth was driven by solid performance across all business segments, with Technology & Analytics Solutions revenue increasing 5.0% to $1.63 billion and Research & Development Solutions revenue rising 4.5% to $2.26 billion compared to the same period last year.
"IQVIA delivered a strong quarter with revenue and profit towards the high-end of our guide, and record free cash flow generation," said Ari Bousbib, chairman and CEO of IQVIA.
"R&DS continued to perform well, with strong demand across all customer segments and improved client decision timelines leading to 13% growth in net bookings year-over-year."
The company reported third-quarter GAAP net income of $331 million, or $1.93 per diluted share, while adjusted EBITDA increased 1.1% to $949 million. Free cash flow surged 35% YoY to $772 million, representing 150% of adjusted net income.
R&D Solutions bookings remained robust at $2.6 billion for the quarter, resulting in a book-to-bill ratio of 1.15x. The contracted backlog grew 4.1% YoY to $32.4 billion.
IQVIA reaffirmed its full-year 2025 guidance, narrowing the ranges to revenue between $16.15 billion and $16.25 billion and adjusted earnings per share between $11.85 and $11.95, in line with analyst expectations of $11.87 per share.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.